Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Genzyme announces launch of instrument line

Jan. 10, 1997

Hyal receives notice of allowance for cardiovascular applications of hyaluronic acid

Jan. 10, 1997

Clinical results with Natrecor in CHF patients reported in Circulation

Jan. 10, 1997

Roche describes antiproliferative agents

Jan. 10, 1997

Preclinical pharmacology profile of BMS NEP/ACE inhibitors described

Jan. 8, 1997

Tokyo Tanabe describes agents for cardiovascular/respiratory disorders

Jan. 8, 1997

Beta-blockers underused

Jan. 7, 1997

P&U discontinues development of agent for DVT; Cytel regains development rights

Jan. 7, 1997

Andrx freed to market Dilacor XR bioequivalent

Jan. 3, 1997

bFGF enters clinical trials for PVD

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...